Abstract
Dihydrotestosterone is crucial for normal development of external genitalia and prostate in the male embryo. Autosomal recessive mutations in the 5α-reductase type 2 (SRD5A2) gene disrupt the synthesis of dihydrotestosterone in the urogenital tract and give rise to genetic males with undervirilized external genitalia that may be female-like or ambiguous. In this study, three unrelated 46,XY children (0.5, 3, and 8 years old) who presented severe undermasculinization at birth were examined for genetic abnormalities in the SRD5A2 gene. Coding sequence abnormalities were ascertained by exon-specific polymerase chain reaction (PCR), single-stranded conformational polymorphism (SSCP), and sequencing analysis. Functional properties of the mutant alleles were investigated by means of site-directed mutagenesis assays. DNA molecular studies showed that all three patients were compound heterozygotes for SRD5A2 mutations. Patient 1 had a point mutation 547G → A in exon 3 (G183S) and a novel dinucleotidic mutation 634,635CC → TG in exon 4 (P212X). This double change results in premature termination signal (TGA) at codon 212, which predicts the expression of a truncated 211-amino acid protein. Patient 2 was the carrier of mutations G115D in exon 3 and S210F in exon 4. Patient 3 had two substitution mutations in exon 1, including a novel G → C transversion at nucleotide 169 (E57Q) and a G → A transition at nucleotide 254 (G85D). In transitory transfection assays, the recombinant cDNAs harboring mutations E57Q and G85D showed residual 5α-reductase activity, whereas those with mutations G115D, S210F, and P212X were devoided of activity. In contrast, the G183S substitution affected the catalytic activity of the enzyme by decreasing its affinity for testosterone substrate. We describe six different mutations of the SRD5A2 gene detected in three children with genital ambiguity. These genotypes are consistent with the clinical phenotype of steroid 5α-reductase 2 deficiency. Our data suggest that the combined gene variants (E57Q/G85D, G115D/S210F, and G183S/P212X) result in subfunctional or nonfunctional enzymes, causing masculinization defects in these patients. This further underscores that exon 4 of SRD5A2 may be a site prone to inactivating mutations.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Andersson S, Berman DM, Jenkins EP, Russell DW (1991) Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 354:159–161
Cai L-Q, Zhu Y-S, Katz MD, Herrera C, Baéz J, DeFillo-Ricart M, Shackleton CHL, Imperato-McGinley J (1996) 5α-Reductase-2 gene mutations in the Dominican Republic. J Clin Endocrinol Metab 81:1730–1735
Canto P, Vilchis F, Chávez B, Mutchinick O, Imperato-McGinley J, Pérez-Palacios G, Ulloa-Aguirre A, Méndez JP (1997) Mutations of the 5α-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5α-reductase-2 deficiency. Clin Endocrinol 46:155–160
Chávez B, Valdéz E, Vilchis F (2000) Uniparental disomy in steroid 5α-reductase 2 deficiency. J Clin Endocrinol Metab 85:3147–3150
Fernández-Cancio M, Nistal M, Gracia R, Molina MA, Tovar JA, Esteban C, Carrascosa A, Audi L (2004a) Compound heterozygous mutations in the SRD5A2 gene exon 4 in a male pseudohermaphrodite patient of Chinese origin. J Androl 25:412–416
Fernández-Cancio M, Rodo J, Andaluz P, deOsaba MJM, Rodríguez-Hierro F, Esteban C, Carrascosa A, Audi L (2004b) Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115/R246W) in SRD5A2 gene. Horm Res 62:259–264
Griffin JE, McPhaul MJ, Russell DW, Wilson JD (2001) The androgen resistance syndromes: steroid 5α-reductase 2 deficiency, testicular feminization, and related disorders. In: Scriver CR et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 4117–4146
Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE (1974) Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186:1213–1215
Labrie F, Sugimoto Y, Luu-The V, Simard J, Lachance Y, Bachvarov D, Leblanc G, Durocher F, Paquet N (1992) Structure of human type II 5α-reductase gene. Endocrinology 131:1571–1573
Makridakis N, Akalu A, Reichardt JKV (2004) Identification and characterization of somatic 5α-reductase (SRD5A2) mutations in human prostate cancer tissue. Oncogene 23:7399–7405
Méndez JP, Ulloa-Aguirre A, Imperato-McGinley J, Brugmann A, Delfín M, Chávez B, Shackleton C, Kofman-Alfaro S, Pérez-Palacios G (1995) Male pseudohermaphroditism due to primary 5α-reductase deficiency: variation in gender identity reversal in seven Mexican patients from five different pedigrees. J Endocrinol Invest 18:205–213
Nicoleti A, Baldazzi L, Balsamo A, Barp L, Pirazzoli P, Gennari M, Radetti G, Cacciari E, Cicognni A (2005) SRD5A2 gene analysis in an Italian population of undermasculinized 46,XY subjects. Clin Endocrinol 63:375–380
Pérez-Palacios G, Chávez B, Méndez JP, Imperato-McGinley J, Ulloa-Aguirre A (1987) The syndromes of androgen resistance revisited. J Steroid Biochem 27:1101–1108
Russell DW, Berman DM, Bryant JT, Cala KM, Davis DL, Landrum CP, Prihoda JS, Silver RI, Thigpen AE, Wigley WC (1994) The molecular genetics of steroid 5α-reductases. Rec Prog Horm Res 49:275–284
Russell DW, Wilson JD (1994) Steroid 5α-reductase: two genes two enzymes. Ann Rev Biochem 63:25–61
Sasaki G, Ogata T, Ishii T, Kosaki K, Sato S, Homma K, Takahashi T, Hasegawa T, Matsuo N (2003) Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients. J Clin Endocrinol Metab 88:3431–3436
Sinnecker GHG, Hiort O, Dibbelt L, Albers N, Dörr HG, Haub H, Heinrich U, Hemminghaus M, Hoepffner W, Holder M, Schnabel D, Krause K (1996) Phenotypic classification of male pseudohermaphroditism due to steroid 5α-reductase 2 deficiency. Am J Med Genet 63:223–230
Thigpen AE, Davis DF, Gautier T, Imperato-McGinley J, Russell DW (1992a) The molecular basis of steroid 5α-reductase deficiency in a large Dominican kindred. N Eng J Med 327:1216–1219
Thigpen AE, Davis DF, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke V, Wilson JD, Russell DW (1992b) Molecular genetics of steroid 5α-reductase 2 deficiency. J Clin Invest 90:799–809
Vilchis F, Canto P, Chávez B, Ulloa-Aguirre A, Méndez JP (1997) Molecular analysis of the 5α-steroid reductase type 2 gene in a family with deficiency of the enzyme. Am J Med Genet 69:69–72
Vilchis F, Méndez JP, Canto P, Lieberman E, Chávez B (2000) Identification of missense mutations in the SRD5A2 gene from patients with steroid 5α-reductase 2 deficiency. Clin Endocrinol 52:383–387
Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson J D (1974) Familial incomplete male pseudohermaphroditism, type 2: decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Eng J Med 291:944–949
Wang YP, Li Q, Xu JJ, Liu QJ, Wang WQ, Lin Y, Ma F, Chen TJ, Li SK, Shen Y (2004) Mutation analysis of five candidate genes in Chinese patients with hypospadias. Eur J Hum Genet 12:706–712
Wigley CW, Prihoda JS, Mowszowics I, Mendonca BB, New MI, Wilson JD, Russell DW (1994) Natural mutagenesis study of the human steroid 5α-reductase 2 isozyme. Biochemistry 33:1265–1270
Wilson JD, Griffin JE, Russell DW (1993) Steroid 5α-reductase 2 deficiency. Endocr Rev 14:577–593
Wilson JD, Griffin JE, Russell DW (1996) Steroid 5α-reductase: one disorder/two enzymes/many unsolved problems. In: Bashin S et al (eds) Pharmacology, biology, and clinical applications of androgens. Wiley-Liss Inc., New York, pp 57–63
Acknowledgments
This work was supported in part by a project grant (44975) and a postgraduate studentship (to LR, Reg. 167215) from CONACyT (México).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vilchis, F., Valdez, E., Ramos, L. et al. Novel compound heterozygous mutations in the SRD5A2 gene from 46,XY infants with ambiguous external genitalia. J Hum Genet 53, 401–406 (2008). https://doi.org/10.1007/s10038-008-0274-2
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s10038-008-0274-2
Keywords
This article is cited by
-
Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
Nature Communications (2020)
-
Practical approach to steroid 5alpha-reductase type 2 deficiency
European Journal of Pediatrics (2011)
-
The IVS1- 2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency
Journal of Endocrinological Investigation (2010)
